BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10917172)

  • 1. Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices.
    Goussia AC; Ioachim EE; Peschos D; Assimakopoulos DA; Skevas A; Agnantis NJ
    Virchows Arch; 2000 Jun; 436(6):579-84. PubMed ID: 10917172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
    Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
    Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.
    Goussia A; Ioachim E; Peschos D; Assimakopoulos D; Vougiouklakis T; Skevas A; Agnantis N
    Anticancer Res; 1999; 19(4B):3055-60. PubMed ID: 10652592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
    Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
    Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of extracellular matrix glycoprotein tenascin in the laryngeal cancer].
    Zhang S; Liu Q; Liu Z; Hua X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):643-5. PubMed ID: 12669429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biopathology of metaplastic, dysplastic, and neoplastic laryngeal epithelium.
    Resta L; Marsigliante S; Leo G; Fiorella R; Di Nicola V; Maiorano E
    Acta Otolaryngol Suppl; 1997; 527():39-42. PubMed ID: 9197478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim E; Goussia A; Agnantis NJ
    Virchows Arch; 1999 Jan; 434(1):45-50. PubMed ID: 10071234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aspects in the pathology of the preneoplastic lesions of the larynx.
    Sugár J; Vereczkey I; Tóth J; Péter I; Bánhidy F
    Acta Otolaryngol Suppl; 1997; 527():52-6. PubMed ID: 9197482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
    Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
    Zhao R; Hirano M; Kurita S
    Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
    Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
    Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.
    Oz B; Karayel FA; Gazio NL; Ozlen F; Balci K
    Pathol Oncol Res; 2000; 6(2):118-24. PubMed ID: 10936787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
    Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
    Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
    Zidar N; Gale N; Cör A; Kambic V
    J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EGF, EGFR and PCNA in laryngeal lesions.
    Wen QH; Nishimura T; Miwa T; Nagayama I; Furukawa M
    J Laryngol Otol; 1995 Jul; 109(7):630-6. PubMed ID: 7561470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H; Sauer U; Schleicher E; Nerlich A
    Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.